Edesa Biotech Inc reports results for the quarter ended in December - Earnings Summary

Edesa Biotech

14/02/2022 15:07

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 33 cents​​ per share for the quarter ended in December. The
lone analyst forecast for the quarter was for a loss of 40 cents
per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Edesa Biotech Inc shares had fallen by 30.9% this quarter.
    * The company reported a quarterly loss of $4.38 million.
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 14 at 03:07 p.m.
 ​All figures in US dollars unless otherwise stated